Amy M. Kilbourne, PhD, MPH

home / authors / amy-m-kilbourne-phd-mph

Articles

December 12th 2014

Sustainable Lifelines: Supporting Integrated Behavioral Health Services for Children and Adolescents in the Accountable Care Era

Amy M. Kilbourne, PhD, MPH Jane Spinner, MSW, MBA Anne Kramer, LMSW Paresh D. Patel, MD, PhD Katherine L. Rosenblum, PhD Richard Dopp, MD Liwei L. Hua, MD, PhD Maria Muzik, MD, MS Sheila M

A reimbursement strategy for collaborative care models is presented to enhance access to integrated behavioral healthcare for children and adolescents from underserved areas.

March 12th 2013

Mental Health in ACOs: Missed Opportunities and Low-Hanging Fruit

Allison N. O'Donnell, MPH Brent C. Williams, MD Daniel Eisenberg, PhD Amy M. Kilbourne, PhD, MPH

This paper describes the rationale and benefits of incorporating mental health into accountable care organizations using the Chronic Care Model.

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com

Published: November 15th 2024 | Updated: November 19th 2024

FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters

Published: April 1st 2024 | Updated: November 5th 2024

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com

Published: October 21st 2024 | Updated: October 24th 2024

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Hurricane | Image credit: Satoshi Kina - stock.adobe.com

Published: September 26th 2024 | Updated: October 1st 2024

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Published: November 1st 2024 | Updated: November 21st 2024

Table Multiple Myeloma Trials November 2024

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions